Evidence map›Paper›PMID 28402950›Full record

ArticleOncotarget2017

Lysosomal lipid hydrolysis provides substrates for lipid mediator synthesis in murine macrophages.

Stefanie Schlager, Nemanja Vujic, Melanie Korbelius, Madalina Duta-Mare, Juliane Dorow, Christina Leopold, Silvia Rainer, Martin Wegscheider, Helga Reicher, Uta Ceglarek and 3 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. From LAL-D to MASLD: Insights into the role of LAL and Kupffer cells in liver inflammation and lipid metabolism.Biochimica et biophysica acta. Molecular and cell biology of lipids · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Recent insights into lysosomal acid lipase deficiency.Trends in molecular medicine · 2023
    Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Stefanie SchlagerInstitute of Molecular Biology and Biochemistry, Medical University of Graz, Graz, Austria.
Nemanja VujicInstitute of Molecular Biology and Biochemistry, Medical University of Graz, Graz, Austria.
Melanie KorbeliusInstitute of Molecular Biology and Biochemistry, Medical University of Graz, Graz, Austria.
Madalina Duta-MareInstitute of Molecular Biology and Biochemistry, Medical University of Graz, Graz, Austria.
Juliane DorowInstitute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University Hospital Leipzig, Leipzig, Germany.
Christina LeopoldInstitute of Molecular Biology and Biochemistry, Medical University of Graz, Graz, Austria.
Silvia RainerInstitute of Molecular Biology and Biochemistry, Medical University of Graz, Graz, Austria.
Martin WegscheiderInstitute of Molecular Biology and Biochemistry, Medical University of Graz, Graz, Austria.
Helga ReicherInstitute of Molecular Biology and Biochemistry, Medical University of Graz, Graz, Austria.
Uta CeglarekInstitute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University Hospital Leipzig, Leipzig, Germany.
Wolfgang SattlerInstitute of Molecular Biology and Biochemistry, Medical University of Graz, Graz, Austria.
Branislav RadovicInstitute of Molecular Biology and Biochemistry, Medical University of Graz, Graz, Austria.
Dagmar KratkyInstitute of Molecular Biology and Biochemistry, Medical University of Graz, Graz, Austria.
Medical University of Graz · ATBioTechMed-Graz · ATLeipzig University · DEUniversity Hospital Leipzig · DE

Funding

Austrian Science Fund FWF P 27070Austrian Science Fund FWF W 1226
6 · The paper itself

Abstract

Degradation of lysosomal lipids requires lysosomal acid lipase (LAL), the only intracellular lipase known to be active at acidic pH. We found LAL to be expressed in murine immune cells with highest mRNA expression in macrophages and neutrophils. Furthermore, we observed that loss of LAL in mice caused lipid accumulation in white blood cells in the peripheral circulation, which increased in response to an acute inflammatory stimulus. Lal-deficient (-/-) macrophages accumulate neutral lipids, mainly cholesteryl esters, within lysosomes. The cholesteryl ester fraction is particularly enriched in the PUFAs 18:2 and 20:4, important precursor molecules for lipid mediator synthesis. To investigate whether loss of LAL activity affects the generation of lipid mediators and to eliminate potential systemic effects from other cells and tissues involved in the pronounced phenotype of Lal-/- mice, we treated macrophages from Wt mice with the LAL-specific inhibitor LAListat-2. Acute inhibition of LAL resulted in reduced release of 18:2- and 20:4-derived mediators from macrophages, indicating that lipid hydrolysis by LAL is an important source for lipid mediator synthesis in macrophages. We conclude that lysosomes should be considered as organelles that provide precursor molecules for lipid mediators such as eicosanoids.

Indexed as

Lipid MetabolismAnimalsCarbamatesCholesterol EstersEicosanoidsFemaleHydrolysisLipidsLysosomesMacrophagesMaleMice, Inbred C57BLMice, KnockoutSterol EsteraseSubstrate SpecificityThiadiazolesCarbamatesCholesterol EstersEicosanoidslalistat 2LipidsSterol EsteraseThiadiazoleseicosanoidsImmune responseImmunityImmunology and Microbiology SectionLAL-Dlipid mediatorlysosomal acid lipaselysosome

Identifiers

PMID28402950
PMCPMC5522325
OpenAlexW2603649233

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.